Valeant to buy Medicis Pharmaceutical
Valeant Pharmaceuticals has entered into agreement with Medicis Pharmaceutical to acquire all of the outstanding common stock of Medicis for $44.00 per share in cash.
Original Article: Valeant to buy Medicis Pharmaceutical
NEXT ARTICLE